Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Formulation Optimization Study for an Immediate-Release Tablet

Author(s):  Kyriacos Soula, Dimassi Hani

Issue:  May/Jun 2009 - Pain Management
View All Articles in Issue

Page(s):  259-261

Formulation Optimization Study for an Immediate-Release Tablet Page 1
Formulation Optimization Study for an Immediate-Release Tablet Page 2
Formulation Optimization Study for an Immediate-Release Tablet Page 3

Download in electronic PDF format for $75

Abstract:  A simple method based on statistical analysis was used to optimize an immediate-release tablet formulation that includes a water-soluble drug. The objective of this study was to optimize different factors to develop a tablet formulation that has good tablet characteristics (hardness of 85 to 90 Newtons), disintegration time between 3 to 6 minutes, and friability <1%. The critical formulation/process factors were the type and concentration of microcrystalline cellulose, the ratio of lactose to microcrystalline cellulose, the concentration of croscarmellose, and the compression force. A two-step approach was implemented. First an optimization study was performed to determine the type of microcrystalline cellulose and its ratio to lactose. Subsequently, a final optimization formulation study was performed based on the results obtained in the preliminary study. Data were analyzed using the SPSS 15 (Statistical Software for Social Sciences). The differences in means between the formulation and the targeted product

Related Keywords: Soula Kyriacos, PhD, Hani Dimassi, PhD, water-soluble drugs, immediate release, formulation development, excipients

Related Categories: EXCIPIENTS, PEER-REVIEWED, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula
, Dimassi Hani
May/Jun 2009
Pg. 259-261

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F
, Wong Keith, Goddard Rob, Johanson Christel
Jan/Feb 2011
Pg. 81-84

Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H
, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001
Pg. 401-405

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
Jan/Feb 2013
Pg. 10-22

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick
, Hernandex-Cardoso Antonio
May/Jun 2011
Pg. 224-232

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Allen Loyd V Jr
Mar/Apr 2011
Pg. 175

In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A
, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Sep/Oct 2013
Pg. 424-431

In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Webster Kathy D
, Al-Achi Antoine, Greenwood Robert
Sep/Oct 1999
Pg. 409-411

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N
, Patel Jayvadan K
Jan/Feb 2023
Pg. 60-71

Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful
, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Jan/Feb 2022
Pg. 80-87

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson
, Holandino Carla
Mar/Apr 2008
Pg. 163-169

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

Return to Top